Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies

pTau181, GFAP, and NfL are associated with more rapid disease progression in MCI-LB and, with further validation, could be useful to support prognosis and stratification for clinical practice and treatment trials. Further work, including clinicopathological studies, is needed to understand the biological correlates of these markers in MCI-LB. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-03-29
DOI
https://doi.org/10.1002/mds.30181
Citations
2
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
2.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies

Rory Durcan, John T. O’Brien, Louise Allan, Michael John Firbank et al.
2 citations
Movement Disorders
Dementia and Cognitive Impairment Research
2.94
article

Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies

Rory Durcan, John T. O’Brien, Louise Allan, Michael John Firbank, Sarah Lawley, Alan Thomas, Kirsty Olsen, Gemma Roberts, Joanna Ciafone, Calum A. Hamilton, Amanda Heslegrave, Nicola Barnett, Henrik Zetterberg, Paul C. Donaghy, Jahfer Hasoon, John‐Paul Taylor
article en
2 citations

Abstract

pTau181, GFAP, and NfL are associated with more rapid disease progression in MCI-LB and, with further validation, could be useful to support prognosis and stratification for clinical practice and treatment trials. Further work, including clinicopathological studies, is needed to understand the biological correlates of these markers in MCI-LB. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(6)
University College London Hospitals NHS Foundation Trust (GB), University of Wisconsin–Madison (US), University of Exeter (GB), University of Cambridge (GB), Sahlgrenska University Hospital (SE), University of California San Diego (US), UK Dementia Research Institute (GB), NIHR Newcastle Biomedical Research Centre (GB), University College London (GB), Newcastle University (GB), University of Gothenburg (SE)
Alzheimer's Society, Weston Family Foundation, UK Dementia Research Institute, GE Healthcare, Medical Research Council, NIHR Newcastle Biomedical Research Centre, UCLH Biomedical Research Centre, NIHR Cambridge Biomedical Research Centre
Openalex Percentile: Top 11%
Dementia and Cognitive Impairment Research
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.